CIK: 0001697228 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 13, 2024
Total Value ($000): $60,100 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IVV | ISHARES TR | 35,758 | $17,079 | 28.4% | $432.25 | — | CORE S&P500 ETF | 464287200 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 73,487 | $17,003 | 28.3% | $182.21 | -4.0% | COM | 558868105 |
| NU | NU HLDGS LTD | 1,909,267 | $15,904 | 26.5% | $4.46 | +81.4% | ORD SHS CL A | G6683N103 |
| — | AKERO THERAPEUTICS INC | 372,575 | $8,700 | 14.5% | $30.94 | — | COM | 00973Y108 |
| — | 89BIO INC | 126,516 | $1,413 | 2.4% | $15.44 | — | COM | 282559103 |